Form 4 Filing: Schneider Eugene Sells $3.7M of $IONS

INSIDER SALE

⚡ MATERIALITY: 7/10

corporate issuer

IONIS PHARMACEUTICALS INC

Ticker: $IONS

Transaction Value

$3.7M

Price/Share: $70.97

transaction date

2026-06-26

Shares: 52,000

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Schneider Eugene, holds the title of EVP, Chf Clinical Develop Ofcr at IONIS PHARMACEUTICALS INC.

On 2026-06-26, the insider transacted 52,000 shares.The shares were transacted at a weighted average price of $70.97 per share, resulting in a total market-relevant value of $3.7M.

Executive Summary Summary

Schneider Eugene (EVP, Chf Clinical Develop Ofcr) sold $3.7M of $IONS

Post-Transaction Position: 77,114 shares

SEC Accession No: 0000874015-26-000216 (CIK: 1838539)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$IONS Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$IONS News Coverage